Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Codex Dna Inc
(NQ:
DNAY
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EST, Jan 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Codex Dna Inc
< Previous
1
2
3
Next >
Mid-Afternoon Market Update: Dow Drops 1%; Snap One Shares Plunge
March 23, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 350 points on Wednesday. The Dow traded down 1.05% to 34,442.47 while the NASDAQ fell 1.09...
Via
Benzinga
Mid-Day Market Update: Nasdaq Turns Positive; 4D pharma Shares Jump
March 23, 2022
The Nasdaq Composite turned higher midway through trading on Wednesday. The Dow traded down 0.69% to 34,566.59 while the NASDAQ rose 0.28% to 14,148.16. The S&P also fell...
Via
Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
March 23, 2022
Gainers Allego N.V. (NYSE: ALLG) shares jumped 158.5% to $21.41 after the company announced the completion of its merger agreement with Spartan Acquisition Corp., which resulted...
Via
Benzinga
Looking Into Codex DNA's Return On Capital Employed
March 23, 2022
Benzinga Pro data, Codex DNA (NASDAQ:DNAY) reported Q4 sales of $3.08 million. Earnings fell to a loss of $12.49 million, resulting in a 27.15% decrease from last quarter. In Q3...
Via
Benzinga
Mid-Morning Market Update: Markets Open Lower; General Mills Posts Upbeat Earnings
March 23, 2022
U.S. stocks opened on downbeat note this morning, with the Dow Jones dropping more than 250 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.80%...
Via
Benzinga
Earnings Scheduled For March 22, 2022
March 22, 2022
Companies Reporting Before The Bell • GDS Holdings (NASDAQ:GDS) is projected to report quarterly loss at $0.18 per share on revenue of $338.69 million. • HUYA (...
Via
Benzinga
45 Stocks Moving In Friday's Mid-Day Session
March 18, 2022
Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) jumped 62.4% to $1.5500. DiDi Global Inc. (NYSE: DIDI) shares climbed 46% to $3.73. Kidpik Corp. (NASDAQ: PIK) shares...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 16, 2022
Gainers
Via
Benzinga
47 Biggest Movers From Yesterday
February 08, 2022
Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 07, 2022
Gainers Agile Therapeutics (NASDAQ:AGRX) ...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 07, 2022
Gainers Nuvectis Pharma (NASDAQ:NVCT) stock moved upwards by 132.3% to $7.55 during Monday's regular session. The current volume of 17.0 million shares is 2307.5% of...
Via
Benzinga
32 Stocks Moving In Monday's Mid-Day Session
February 07, 2022
Gainers Nuvectis Pharma, Inc. (NASDAQ: NVCT) jumped 191.2% to $9.47. The company, on Friday, priced its IPO at $5 per share. Anghami Inc. (NASDAQ: ANGH) shares jumped 51% to $18....
Via
Benzinga
Pfizer Continues Its Covid Makeover: What's Next For This Hot Stock?
January 13, 2022
How the pandemic continued a transformation Pfizer says began years ago.
Via
Investor's Business Daily
52 Biggest Movers From Friday
January 18, 2022
Gainers Splash Beverage Group, Inc. (NASDAQ: SBEV) shares gained 118.9% to settle at $4.18 on Friday. Splash Beverage recently announced it has received authorization to sell its...
Via
Benzinga
Biotech Bloodbath Continues Despite Gene-Editing Deals For Pfizer, Bayer
January 10, 2022
Pfizer and Bayer inked deals with several companies in gene-editing.
Via
Investor's Business Daily
Why Codex DNA Shares Are Trading Higher Today?
January 10, 2022
Pfizer Inc (NYSE: PFE) has signed on two partners in an effort to become an mRNA powerhouse. Pfizer will offer milestone payments of over $100 million to ...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
December 31, 2021
Gainers Nutriband (NASDAQ:NTRB) stock moved upwards by 186.7% to $11.21 during Friday's regular session. The current volume of 101.5 million shares is 7226.8% of...
Via
Benzinga
63 Biggest Movers From Yesterday
December 31, 2021
Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its...
Via
Benzinga
45 Biggest Movers From Yesterday
December 30, 2021
Gainers Puxin Limited (NYSE: NEW) shares surged 80% to close at $0.54 on Wednesday after reporting results for the second quarter. United Time Technology Co., Ltd. (NASDAQ: UTME...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 29, 2021
Gainers Cognition Therapeutics (NASDAQ:CGTX
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 29, 2021
Gainers Biofrontera (NASDAQ:
Via
Benzinga
26 Stocks Moving In Wednesday's Mid-Day Session
December 29, 2021
Gainers Puxin Limited (NYSE: NEW) jumped 100.5% to $0.6016 after reporting results for the second quarter. ShiftPixy, Inc. (NASDAQ: PIXY) climbed 38.4% to $1.55 after surging 43...
Via
Benzinga
54 Biggest Movers From Thursday
December 27, 2021
Gainers 22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 23, 2021
Gainers Pasithea Therapeutics (NASDAQ:
Via
Benzinga
Codex DNA, Inc. (DNAY) Q3 2021 Earnings Call Transcript
November 10, 2021
DNAY earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
Codex DNA Clocks Q3 Sales Growth Of 75%; Acquires Eton Bioscience For $13M
November 10, 2021
Codex DNA Inc's (NASDAQ: DNAY) Q3 revenues increased 75% Y/Y to $2.8 million. The total fell short of the consensus Wall Street estimate of $2.93 million. Q3 was...
Via
Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...
Via
Benzinga
48 Biggest Movers From Yesterday
September 21, 2021
Gainers Edesa Biotech, Inc. (NASDAQ: EDSA) shares climbed 102.7% to settle at $11.92 on Monday after the company disclosed Phase 2 data of its monoclonal antibody in hospitalized...
Via
Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.